Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference25 articles.
1. Advanced breast cancer;Macaulay,1986
2. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer;Steiner;Eur J Cancer Clin Oncol,1983
3. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer;Jain;J Clin Oncol,1985
4. Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours;Stuart-Harris;Cancer Chemother Pharmacol,1982
5. Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients;Cornbleet;Eur J Cancer Clin Oncol,1984
Cited by 81 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study;European Journal of Cancer;2022-11
2. Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study;Cancer Research and Treatment;2022-10-15
3. The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice;Critical Reviews in Oncology/Hematology;2020-09
4. Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer;Acta Oncologica;2020-03-06
5. A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial;Annals of Oncology;2018-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3